PAVmed Financials

PAVM Stock  USD 0.77  0.01  1.32%   
Based on the measurements of operating efficiency obtained from PAVmed's historical financial statements, PAVmed Inc may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, PAVmed's Other Stockholder Equity is very stable compared to the past year. As of the 19th of March 2025, Total Liabilities is likely to grow to about 69 M, though Total Stockholder Equity is likely to grow to (46 M). Key indicators impacting PAVmed's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio0.490.52
Notably Down
Slightly volatile
The essential information of the day-to-day investment outlook for PAVmed includes many different criteria found on its balance sheet. An individual investor should monitor PAVmed's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in PAVmed.

Net Income

(54.87 Million)

  

PAVmed Stock Summary

PAVmed competes with Neuropace, Hyperfine, Orthopediatrics Corp, Tela Bio, and MaxCyte. PAVmed Inc. operates as a medical device company in the United States. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York. Pavmed operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 89 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS70387R1068
CUSIP70387R106 70387R403 70387R205
LocationNew York; U.S.A
Business Address360 Madison Avenue,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.pavmed.com
Phone(917) 813 1828
CurrencyUSD - US Dollar

PAVmed Key Financial Ratios

PAVmed Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets19.8M87.0M54.0M33.1M38.1M23.6M
Other Current Liab(15.0M)4.3M3.7M6.6M7.6M8.0M
Net Tangible Assets(6.1M)(641K)57.2M(15.8M)(18.2M)(17.3M)
Net Debt(2.3M)(77.3M)(3.1M)29.1M26.2M27.5M
Retained Earnings(88.3M)(138.9M)(228.2M)(294.4M)(265.0M)(251.7M)
Accounts Payable3.0M3.3M2.7M1.8M2.1M1.9M
Cash17.3M77.3M39.7M19.6M22.6M18.9M
Capital Surpluse32.6M47.6M87.6M198.1M227.8M239.2M
Other Current Assets1.7M5.2M3.9M3.8M4.3M4.1M
Total Liab20.3M7.6M43.0M57.1M65.7M69.0M
Total Current Assets18.9M82.6M43.9M24.5M28.2M20.8M
Common Stock64K86K95K9K10.4K9.8K
Other Assets837K725K1.1M1.01.151.09
Net Invested Capital14.3M59.2M21.3M(12.6M)(14.5M)(13.8M)
Short Long Term Debt8.1M14.7M33.7M44.2M50.8M53.4M
Net Working Capital(1.0M)75.1M2.7M(29.7M)(34.1M)(32.4M)
Short Term Debt8.1M15.0M34.8M45.8M52.6M55.3M
Capital Stock2.6M2.5M2.8M3.0M3.5M2.8M

PAVmed Key Income Statement Accounts

202020212022202320242025 (projected)
Interest Expense53K5.8M1.3M589K677.4K1.2M
Gross Profit(23K)(85K)(3.2M)(4.0M)(3.6M)(3.4M)
Operating Income(23.4M)(54.4M)(90.9M)(68.8M)(61.9M)(58.8M)
Ebit(35.8M)(56.1M)(102.0M)(78.7M)(70.8M)(67.3M)
Research Development11.0M19.8M25.5M14.3M16.4M9.5M
Ebitda(35.8M)(55.9M)(99.4M)(75.7M)(68.2M)(64.8M)
Cost Of Revenue23K585K3.6M6.4M7.4M7.8M
Income Before Tax(35.9M)(56.1M)(103.2M)(79.3M)(71.3M)(67.8M)
Net Income(34.3M)(50.3M)(101.3M)(64.2M)(57.8M)(54.9M)
Income Tax Expense(1.6M)(5.8M)(1.9M)(13.0B)(11.7B)(11.1B)
Minority Interest(2.4M)5.8M14.3M15.8M18.2M19.1M
Net Interest Income(713K)(523K)(1.3M)(448K)(515.2K)(541.0K)
Interest Income5.6M591.3K169K505K454.5K431.8K

PAVmed Key Cash Accounts

202020212022202320242025 (projected)
Change In Cash11.0M60.0M(37.5M)(20.1M)(18.1M)(17.2M)
Net Borrowings6.2M16.7M(14.8M)35.2M40.5M42.5M
Free Cash Flow(22.0M)(42.1M)(72.5M)(52.3M)(47.1M)(44.7M)
Depreciation23K226K2.5M2.9M3.4M3.5M
Other Non Cash Items5.3M(1.5M)11.0M(3.5M)(4.1M)(3.8M)
Capital Expenditures55K1.5M1.5M242K278.3K377.4K
Net Income(35.9M)(56.1M)(103.2M)(64.2M)(57.8M)(54.9M)
End Period Cash Flow17.3M77.3M39.7M19.6M22.6M19.0M
Change To Netincome1.6M12.3M15.1M16.3M18.7M19.6M
Dividends Paid357K436M35.2M12.5B14.4B9.8B
Investments(55K)(3.7M)(4.7M)643K578.7K607.6K

PAVmed Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining PAVmed's current stock value. Our valuation model uses many indicators to compare PAVmed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PAVmed competition to find correlations between indicators driving PAVmed's intrinsic value. More Info.
PAVmed Inc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, PAVmed's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value PAVmed by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

PAVmed Inc Systematic Risk

PAVmed's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. PAVmed volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on PAVmed Inc correlated with the market. If Beta is less than 0 PAVmed generally moves in the opposite direction as compared to the market. If PAVmed Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one PAVmed Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of PAVmed is generally in the same direction as the market. If Beta > 1 PAVmed moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in PAVmed Stock are looking for potential investment opportunities by analyzing not only static indicators but also various PAVmed's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of PAVmed growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.0112

At this time, PAVmed's Price Earnings To Growth Ratio is very stable compared to the past year.

PAVmed March 19, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of PAVmed help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of PAVmed Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of PAVmed Inc based on widely used predictive technical indicators. In general, we focus on analyzing PAVmed Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build PAVmed's daily price indicators and compare them against related drivers.
When determining whether PAVmed Inc is a strong investment it is important to analyze PAVmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PAVmed's future performance. For an informed investment choice regarding PAVmed Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.14)
Revenue Per Share
0.45
Quarterly Revenue Growth
0.259
Return On Assets
(0.96)
Return On Equity
(13.58)
The market value of PAVmed Inc is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed's value that differs from its market value or its book value, called intrinsic value, which is PAVmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed's market value can be influenced by many factors that don't directly affect PAVmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PAVmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.